BI 764198

BI-764198 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for BI 764198, covering 2022-04-11 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Results: A Study in Healthy Men to Test How BI 764198 is Processed in the Body [Phase 1]